Article

invezz.com on 2022-04-12 14:38

Bicycle Therapeutics reports promising BT8009 study results, shares tank 30%

Bicycle Therapeutics reports promising Phase 1/2 BT8009 study results confirming preliminary anti-tumor results

Related news